More articles from Bench to Bedside
-
Potential molecular therapy for acute renal failure
Ben H. Brouhard, MD and H. David Humes, MD- Cleveland Clinic Journal of Medicine March 1993, 60 (2) 166-168;
As more is learned about renal epithelial cell regeneration and differentiation, exogenously administered growth promoters seem a likely intervention.
-
Myasthenia gravis therapy: immunoadsorbent may eliminate need for plasma products
Ben H. Brouhard, MD, Koji Sawada, MD, Paul S. Malchesky, DEng, Anna P. Koo, MD and Hiroshi Mitsumoto, MD- Cleveland Clinic Journal of Medicine January 1993, 60 (1) 60-64;
This new technique accomplished nearly complete removal of anti-acetylcholine receptor antibody with minimal loss of albumin.
-
Cytokines and the pathogenesis of insulin-dependent diabetes mellitus
Ben H. Brouhard, MD- Cleveland Clinic Journal of Medicine November 1992, 59 (6) 629-633;
-
Calcium-channel blocking agents as therapy for amphotericin B nephrotoxicity
Ben H. Brouhard, MD and Barbara Baetz-Greenwalt, MD- Cleveland Clinic Journal of Medicine May 1992, 59 (3) 263-264;
Concomitant use of calcium-channel blockers may prevent nephrotoxicity and permit use of full therapeutic doses of amphotericin B in systemic fungal infection.
-
Use of angiotensin-converting enzyme inhibitors in chronic progressive renal disease
Ben H. Brouhard, MD, Kimberly C. Irwin, MD, Robert J. Cunningham, MD and Nicholas T. Stowe, PHD- Cleveland Clinic Journal of Medicine March 1991, 58 (2) 184-190;
In chronic renal disease, ACE inhibition may counteract certain changes that lead to end-stage renal failure.
-
A new intracellular flush solution improves renal transplant preservation
Ben H. Brouhard, MD, Peter N. Bretan, MD and Andrew C. Novick, MD- Cleveland Clinic Journal of Medicine January 1991, 58 (1) 54-58;
A new renal preservation flush solution minimizes the ischemic injury that occurs during hypothermic storage and reperfusion.
-
Lipoprotein abnormalities in the progression of renal disease
Ben H. Brouhard, MD, Michael D. Cressman, DO, Kimberly C. Irwin, MD and Nicholas T. Stowe, PhD- Cleveland Clinic Journal of Medicine October 1990, 57 (7) 599-604;
Animal models suggest that lipid-dowering agents may benefit patients with chronic progressive renal disease.
-
New Series
Ben H. Brouhard, MD- Cleveland Clinic Journal of Medicine September 1990, 57 (6) 512;
An innovative series will address issues in basic science that are relevant to the practice of medicine.
-
Intra-arterial chemotherapy for brain tumors
Ben H. Brouhard, MD, Samuel J. Hassenbusch, MD, PhD, James H. Anderson, PhD and Donald M. Whiting, MD- Cleveland Clinic Journal of Medicine September 1990, 57 (6) 513-520;
A program involving rabbit and human protocols demonstrates the successful integration of basic and clinical research with practical applications.